ziprasidone hydrochloride · Viatris · NDA 020825, 020919, 021483

Geodon

Earliest generic entry, as listed · earliest of 5 marketed strengths

Open now

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 6

NDA · product	Form	Strength	Approved	Listed expiry
020825 · 001 · RLD	capsule, oral	EQ 20MG BASE	5 Feb 2001	open
020825 · 002 · RLD	capsule, oral	EQ 40MG BASE	5 Feb 2001	open
020825 · 003 · RLD	capsule, oral	EQ 60MG BASE	5 Feb 2001	open
020825 · 004 · RLD	capsule, oral	EQ 80MG BASE	5 Feb 2001	open
020919 · 001 · RLD	powder, intramuscular	EQ 20MG BASE/VIAL	21 Jun 2002	open
021483 · 001 · discontinued	suspension, oral	EQ 10MG BASE/ML	29 Mar 2006	open